Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders
BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-020-4922-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 6, 2020
Authors
Publisher
Springer Science and Business Media LLC